Quest PharmaTech Receives US $2M for its Immuno-Photodynamic Therapy Assets
Edmonton-based Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products to improve the quality of life, announced the sale of its Immuno-photodynamic therapy assets to its subsidiary company, OncoQuest Inc. for US $2 million.